Protagonist Therapeutics, Inc (PTGX) › Total LiabilitiesProtagonist Therapeutics, Inc (PTGX) — Total LiabilitiesAnnual figures by period end, from SEC filings.2015-12-31: $5.25M2016-12-31: $6.43M2017-12-31: $43.10M2018-12-31: $26.96M2019-12-31: $74.95M2020-12-31: $44.86M2021-12-31: $47.67M2022-12-31: $32.32M2023-12-31: $21.27M2024-12-31: $69.43M2025-12-31: $53.48M$53.48M2015-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$53.48M-23.0%2026-02-25Balance as of period end2024-12-31$69.43M+226.4%2026-02-25Balance as of period end2023-12-31$21.27M-34.2%2025-02-21Balance as of period end2022-12-31$32.32M-32.2%2024-02-27Balance as of period end2021-12-31$47.67M+6.3%2023-03-15Balance as of period end2020-12-31$44.86M-40.1%2022-02-28Balance as of period end2019-12-31$74.95M+178.0%2021-03-10Balance as of period end2018-12-31$26.96M-37.5%2020-03-10Balance as of period end2017-12-31$43.10M+569.8%2019-03-12Balance as of period end2016-12-31$6.43M+22.6%2018-03-07Balance as of period end2015-12-31$5.25M—2017-03-07Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)